Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
This dose reduction strategy significantly reduces long-term costs while maintaining weight loss benefits
Opt for fresh, whole foods and use herbs and spices for flavoring
Just two weeks later, on 1 April 2026, the FDA approved Foundayo, Eli Lillys brand name for orforglipron, making it the first small-molecule, non-peptide oral GLP-1 receptor agonist approved for chronic weight management
Our previous articles, Alert: Tirzepatide No Longer on FDAs Drug Shortage List and Alert: Tirzepatide and Semaglutide Still on the Drug Shortage List, provide valuable insights into the evolving situation and the steps taken to address the shortages
